Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Jan;96(1):e1-3; author reply e4.
doi: 10.3324/haematol.2010.036640.

Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies

Enrico Maria Trecarichi, Mario Tumbarello, Morena Caira, Anna Candoni, Chiara Cattaneo, Domenico Pastore, Rosa Fanci, Annamaria Nosari, Nicola Vianelli, Alessandro Busca, Antonio Spadea, Livio Pagano
Comment

Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies

Enrico Maria Trecarichi et al. Haematologica. 2011 Jan.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Percentages of in vitro resistance of P. aeruginosa strains to major antibiotic classes, according to multi-drug resistance of isolates. (Aminoglycosides: amikacin and gentamicin; anti-pseudomonal cephalosporins: cefepime and ceftazidime; carbapenems: meropenem and imipenem; fluoroquinolones: ciprofloxacin and levofloxacin).
See this image and copyright information in PMC

Comment on

References

    1. Caselli D, Cesaro S, Ziino O, Zanazzo G, Manicone R, Livadiotti S, et al. Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation. Haematologica. 2010;95(9):1612–5. - PMC - PubMed
    1. Lodise TP, Jr, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007;51(10):3510–5. - PMC - PubMed
    1. Giske CG, Monnet DL, Cars O, Carmeli Y. ReAct-Action on Antibiotic Resistance. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813–21. - PMC - PubMed
    1. Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer. 2010;116(4):967–73. - PubMed
    1. Tumbarello M, Spanu T, Caira M, Trecarichi EM, Laurenti L, Montuori E, et al. Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis. 2009;64(3):320–6. - PubMed

MeSH terms

Substances